Methods and systems for identifying candidate nucleic acid agent

Inventors

WANG, JinpengFerguson, BrianGong, Qiang

Assignees

APTITUDE MEDICAL SYSTEMS Inc

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-11041849-B2

Patent

Publication Date

2021-06-22

Expiration Date


Abstract

The present disclosure provides methods, kits and compositions for identifying nucleic acid agents having a desired property, e.g., a property of specifically binding to a target (such as a protein target) with high affinity. More specifically, the present disclosure provides methods, kits and compositions for identifying candidate nucleic acid agents with both high specificity and affinity for a target.

Core Innovation

The invention provides a method for identifying one or more nucleic acid agents having a desired property from a mixture of candidate nucleic acid agents, where the desired property includes specific binding to a target with high affinity. The mixture comprises a plurality of aptamers, and the method uses a particle-based approach in which candidate nucleic acid agents are immobilized on particles, with each particle containing at most a subset of the candidate nucleic acid agents.

Particles are exposed to a screening composition comprising a target moiety and a reference moiety. An interaction with the target moiety is indicated by a first signal, an interaction with the reference moiety is indicated by a second signal, and the intensities of the first signal and the second signal provide a sorting parameter for a particular particle. The concentration of the target moiety and the concentration of the reference moiety are set to enable the sorting parameter of about 0.05% to about 1% of the particles to be within a predetermined sorting range.

Selected particles having a sorting parameter within the predetermined sorting range are isolated, and the one or more nucleic acid agents having the desired property are identified from the one or more selected particles. In dependent aspects, intensity-based threshold rules define the predetermined sorting range using first-signal and second-signal thresholds, prescreening defines the thresholds using first prescreening and second prescreening compositions, and iterative rounds generate an enriched mixture for repeated screening.

Claims Coverage

The claims cover a particle-based identification method for nucleic acid agents using dual target and reference signals and a sorting parameter defined by those signal intensities. The inventive features include 10 merged features across the independent and dependent claims.

Particle-immobilized candidate aptamers in subsets

providing a plurality of particles with the candidate nucleic acid agents immobilized thereon, wherein each of the plurality of particles comprises at most a subset of the candidate nucleic acid agents within said mixture

Target and reference moiety dual-signal sorting parameter

exposing the plurality of particles to a screening composition comprising a target moiety and a reference moiety, wherein an interaction of said candidate nucleic acid agents with the target moiety is indicated by a first signal, an interaction of said candidate nucleic acid agents with the reference moiety is indicated by a second signal, and an intensity of said first signal together with an intensity of said second signal for a particular particle provide a sorting parameter of the particular particle

Low-population sorting range via set target/reference concentrations

wherein a concentration of the target moiety and a concentration of the reference moiety are respectively set at a value enabling the sorting parameter of about 0.05% to about 1% of the plurality of particles to be within a predetermined sorting range

Isolating selected particles and identifying nucleic acid agents

isolating from said plurality of particles one or more selected particles having a sorting parameter within said predetermined sorting range, wherein the one or more selected particles comprises said one or more nucleic acid agents having the desired property; and identifying the one or more nucleic acid agents having the desired property from the one or more selected particles

First and second signal intensity threshold selection

wherein the predetermined sorting range comprises selecting particles based on the first signal and the second signal being respectively within first and second intensity thresholds

Prescreening-defined first threshold from target-only composition

determining a first threshold using a first prescreening composition that comprises the target moiety and does not comprise the reference moiety, and wherein the first threshold is based on a maximum mean intensity of the first signal

Prescreening-defined second threshold proportional to reference-only maximum

setting a second threshold based on a maximum mean intensity of the second signal obtained from a second prescreening composition that comprises the reference moiety

Reference moiety as a protein or polypeptide

wherein the reference moiety is a protein or a polypeptide moiety

Named protein target moiety embodiments

wherein the target moiety comprises a protein selected from a group including Tumor Necrosis Factor α and Integrins

Iterative rounds using enriched mixture

forming a screening round by performing operations a), b), c), and generating an enriched mixture from selected particles, and repeating for two or more said rounds of screening using the enriched mixture in a next round

Overall, the claims cover selecting high-affinity specific-binding aptamers by immobilizing candidate aptamers on particles, exposing the particles to target/reference dual-moiety screening to produce first and second signals, and sorting via a sorting parameter that captures both signals within a predetermined low-percentage sorting range, with dependent claims refining threshold determination and iterative enrichment across multiple screening rounds.

Stated Advantages

Not explicitly described in patent.

Documented Applications

Not explicitly described in patent.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.